share_log
Breakings ·  Sep 3 19:01
Precision BioSciences Receives $13 Million in Proceeds From Imugene Convertible Note Maturity as Part of the August 2023 Azer-Cel Deal
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment